Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Oakmark Global Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Oakmark Global delivered solid Q2 performance while maintaining YTD outperformance since inception. The fund added three new positions in undervalued life sciences and insurance companies - Corebridge Financial, Danaher, and IQVIA Holdings - while exiting four positions that approached sell targets or faced management concerns."
The Oakmark Global Fund returned 4.3% in Q2 2023, slightly lagging the MSCI World Index's 6.8% return, but maintained its YTD lead at 15.3% versus 15.1%. Since inception in 1999, the fund has delivered a 9.4% annualized return compared to 5.7% for the benchmark. The quarter's top contributors were Alphabet and Amazon, while Alibaba and Anheuser-Busch InBev were the largest detractors. The fund initiated three new positions: Corebridge Financial, a life insurance company trading at five times normalized cash flow; Danaher, a life sciences leader positioned in high-growth niches like biologics and genomics; and IQVIA Holdings, a clinical research organization benefiting from trends toward personalized medicine. The fund eliminated positions in Arconic, Tenet Healthcare, Cushman & Wakefield, and NOV, with proceeds partially redeployed to ConocoPhillips. Geographically, the portfolio remains diversified with 47% in the US, 34% in Europe, 14% in the UK, and 5% in Asia.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
The fund demonstrates moderate-high conviction through concentrated positioning and detailed thesis explanations for new holdings. The managers provide specific valuation metrics (5x cash flow for Corebridge, 15x earnings for IQVIA) and clear catalysts. However, the diversified global portfolio with 19 named holdings and hedged language around timing prevents a higher score.
Growth Outlook
The letter presents a constructive but measured market outlook. While the fund continues to find attractive opportunities and initiated three new positions, there's no explicit bullish commentary about broader market conditions. The tone is professional and focused on individual stock selection rather than market-wide optimism.
Risk Appetite
The fund demonstrates selective risk appetite by initiating three new positions while eliminating four others. The managers are actively deploying capital into what they view as attractive opportunities, particularly in life sciences, but maintain disciplined position management by exiting holdings that reached targets or faced issues.
Capital Deployment
The fund shows modest net deployment activity by initiating three new positions while eliminating four. This represents capital rotation rather than aggressive deployment, as proceeds from exits were used to fund new positions. No cash level changes are disclosed, suggesting neutral to slightly positive deployment.
Forward Guidance
The forward guidance is cautiously optimistic with selective deployment bias. The managers express willingness to wait for catalysts (Corebridge ownership overhang resolution) and believe near-term headwinds will prove short-lived (Danaher). However, there's no aggressive deployment mandate or strong conviction about immediate opportunities.
Language Signal
The language contains more positive than negative directional signals. Terms like 'highly attractive,' 'excellent track record,' 'attractive entry point,' and 'pleased to be able to add' outweigh cautious language. However, the letter is largely descriptive and analytical rather than directionally charged.
Perceived Risk
Risk perception is relatively low with only brief mentions of standard investment risks in boilerplate language. The managers acknowledge near-term headwinds for Danaher and management concerns at Cushman & Wakefield, but these are company-specific rather than systemic risks. No macro or market-wide risk concerns are discussed.
Opportunity Density
The managers demonstrate a selective but positive view of opportunities, successfully identifying three new attractive investments during the quarter. The detailed analysis of new positions and willingness to exit others suggests they can find compelling ideas but remain selective. The tone suggests opportunities exist for disciplined investors.
Time Horizon
The fund exhibits a long-term investment horizon with explicit patience for catalysts. The managers state they are 'willing to wait for the ownership overhang to resolve itself' for Corebridge and believe Danaher's near-term headwinds 'will ultimately prove short-lived.' The focus on secular growth trends and fundamental value suggests multi-year investment horizons.
